4BIO CAPITAL
4BIO Ventures is a London-based firm investing in venture capital and public equities in life sciences. They are focused on advanced therapies addressing high unmet medical and social needs. 4BIO Capital Partners is an emerging asset manager focusing on private equity and venture capital in high growth and high return segments of biotech - biologics, gene and cell therapy and bioinformatics.
4BIO CAPITAL
Industry:
Genetics
Founded:
2014-12-01
Status:
Active
Contact:
+44 (0) 203 427 5500
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Apollo Health Ventures
Apollo Health Ventures is a venture capital firm investing in seed and early stage biotechnology companies.
Batavia Biosciences
Batavia Biosciences focuses on accelerating the transition of biopharmaceutical product
Calimmune
Calimmune is a clinical-stage gene therapy company.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-07 | Code Biotherapeutics | 4BIO Capital investment in Series A - Code Biotherapeutics | 75 M USD |
| 2022-06-06 | LUCA Science | 4BIO Capital investment in Series B - LUCA Science | 3.86 B JPY |
| 2022-01-04 | Ray Therapeutics | 4BIO Capital investment in Seed Round - Ray Therapeutics | 6 M USD |
| 2021-04-20 | Code Biotherapeutics | 4BIO Capital investment in Seed Round - Code Biotherapeutics | 10 M USD |
| 2021-03-01 | Carisma Therapeutics | 4BIO Capital investment in Series B - Carisma Therapeutics | 12 M USD |
| 2020-10-22 | Araris Biotech | 4BIO Capital investment in Seed Round - Araris Biotech | 15.2 M CHF |
| 2020-10-21 | SparingVision | 4BIO Capital investment in Venture Round - SparingVision | 44.5 M EUR |
| 2020-03-25 | Redpin Therapeutics | 4BIO Capital investment in Series A - Redpin Therapeutics | 15.5 M USD |
| 2018-01-01 | Autolus | 4BIO Capital investment in Post-IPO Equity - Autolus | N/A |
| 2017-12-20 | Orchard Therapeutics | 4BIO Capital investment in Series B - Orchard Therapeutics | 110 M USD |
More informations about "4BIO Capital"
4BIO Capital | Venture Investment | Greater London
4BIO Capital is a London-based venture capital firm focused solely on the advanced therapies sector. 4BIO’s objective is to invest in, support, and grow early stage companies developing treatments in areas of high unmet medical …See details»
4BIO Capital - Crunchbase Investor Profile & Investments
4BIO Ventures is a London-based firm investing in venture capital and public equities in life sciences. They are focused on advanced therapies addressing high unmet medical and social needs. 4BIO Capital Partners is an emerging asset …See details»
4BIO Capital - Investments, Portfolio & Company Exits - Crunchbase
Jun 7, 2022 4BIO Capital 's most notable exits include Carisma Therapeutics, ... Which industries has this organization had the most exits in? Show . Carisma Therapeutics Carisma …See details»
4BIO Capital Becomes First UK Venture Fund Certified by
Nov 14, 2024 Philippe Fauchet, Venture Partner at 4BIO Capital, commented: “Collaborating with AMED to support the most innovative Japanese biotech startups is an exciting opportunity …See details»
4Bio Capital - Investor Profile, Portfolio & Team - Tracxn
Jan 29, 2025 4Bio Capital is a venture capital firm founded in 2014.It is primarily based out of London, United Kingdom. As of Oct 2024, 4Bio Capital is an active investor, having invested in …See details»
4BIO Capital - The Org
4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector. 4BIO’s objective is to invest in, support, and grow early stage companies developing …See details»
4BIO Capital – Investors Database - Unicorn Nest
This 4BIO Capital works on 51 percentage points more the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 50 - 100 millions dollars. ... This organization …See details»
4BIO Capital
Jan 14, 2025 4BIO Capital is a Londonbased venture Capital firm that invests in both private Equity and public equities within the life sciences sector. The firm specializes in advanced …See details»
4BIO Capital - Funding, Financials, Valuation & Investors
4BIO Capital has raised a single venture fund, 4Bio Ventures II. This fund was announced on Sep 8, 2019 and raised a total of . obfuscated. obfuscated. Announced Date . Fund Name . Money …See details»
4BIO Capital announces promotion of Owen Smith to …
Mar 2, 2022 LONDON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm focused solely on the advanced therapies sector, today announced the promotion of Owen Smith, MSc (Oxon), CPFA, to Partner and …See details»
4BIO Capital Strengthens Investment Team - GlobeNewswire
Nov 4, 2024 4BIO Capital +44 (0) 203 427 5500 [email protected] ICR Healthcare Amber Fennell, Jon Edwards, Kris Lam +44 (0)20 3709 5700 [email protected]See details»
4BIO Capital - Investing in a future where advanced therapies are …
Sep 13, 2024 London-based venture capital firm, 4BIO Capital, believes in a future where advanced therapies are the standard of care. Founded in 2015, the firm has built a global …See details»
4BIO Capital Portfolio Company Araris Biotech to be
5 days ago 4BIO Capital +44 (0) 203 427 5500 [email protected] ICR Healthcare Amber Fennell, Jonathan Edwards, Kris Lam +44 (0)20 3709 5700 [email protected]See details»
4BIO Capital Portfolio Company Trogenix Unveils Revolutionary …
LONDON, 18 November 2024 – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm unlocking the treatments of the future by investing in advanced therapies and other ...See details»
4BIO Capital
4BIO Capital is a Londonbased venture capital firm that invests in both private equity and public equities within the life sciences sector. The firm specializes in advanced therapies, including …See details»
4BIO Capital Portfolio Company Entact Bio Launches with $81 …
Dec 6, 2022 Press Release 4BIO Capital Portfolio Company Entact Bio Launches with $81 Million Series A to Develop Precision Medicines for Targeted Protein Enhancement …See details»
4BIO Capital Portfolio Company Araris Biotech to be Acquired by …
5 days ago 4BIO Capital (“4BIO”) is an international venture capital firm focused on investing in advanced therapies, including genomic medicines and other emerging technologies, to unlock …See details»
4BIO Capital Portfolio Company Redpin Therapeutics to be …
Nov 16, 2022 Press Release 4BIO Capital Portfolio Company Redpin Therapeutics to be Acquired by Kriya Therapeutics 16 November 2022 London & New York – 4BIO Capital …See details»
4BIO Capital Portfolio Company Redpin Therapeutics to be
Nov 16, 2022 4BIO Capital +44 (0) 203 427 5500 [email protected] Consilium Strategic Communications Amber Fennell, Andrew Stern, Genevieve Wilson +44 (0)20 3709 5700See details»
4BIO Capital Portfolio Company Araris Biotech to be Acquired by …
5 days ago 4BIO Capital ("4BIO”) is an international venture capital firm focused on investing in advanced therapies, including genomic medicines and other emerging technologies, to unlock …See details»